Sarcos Technology [STRC] vs Oracle [ORCL] Detailed Stock Comparison
Sarcos Technology
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sarcos Technology wins in 5 metrics, Oracle wins in 8 metrics, with 0 ties. Oracle appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sarcos Technology | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 57.48 | N/A |
| Price-to-Book Ratio | N/A | 34.32 | N/A |
| Debt-to-Equity Ratio | 0.16 | 519.59 | Sarcos Technology |
| PEG Ratio | N/A | 34.92 | N/A |
| EV/EBITDA | -745.74 | 34.09 | Sarcos Technology |
| Profit Margin (TTM) | 72.06% | 21.68% | Sarcos Technology |
| Operating Margin (TTM) | -404.01% | 32.48% | Oracle |
| EBITDA Margin (TTM) | N/A | 32.48% | N/A |
| Return on Equity | -6.40% | 82.38% | Oracle |
| Return on Assets (TTM) | -4.51% | 7.26% | Oracle |
| Free Cash Flow (TTM) | $-22.14B | $-394.00M | Oracle |
| Dividend Yield | 0.83% | 0.81% | Sarcos Technology |
| 1-Year Return | 6,231.17% | 89.35% | Sarcos Technology |
| Price-to-Sales Ratio (TTM) | 51.71 | 12.24 | Oracle |
| Enterprise Value | $31.17B | $800.62B | Oracle |
| EV/Revenue Ratio | 67.26 | 13.95 | Oracle |
| Gross Profit Margin (TTM) | 68.77% | 70.19% | Oracle |
| Revenue per Share (TTM) | N/A | $21 | N/A |
| Earnings per Share (Diluted) | N/A | $4.35 | N/A |
| Beta (Stock Volatility) | N/A | 1.43 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sarcos Technology vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sarcos Technology | -0.09% | 3.57% | 1,057.96% | 1,440.28% | 705.12% | 729.08% |
| Oracle | 0.26% | 2.30% | 6.63% | 66.37% | 39.76% | 50.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sarcos Technology | 6,231.17% | 336.83% | 65.99% | 65.99% | 65.99% | 65.99% |
| Oracle | 89.35% | 215.92% | 361.35% | 534.48% | 1,003.49% | 1,780.08% |
Performance & Financial Health Analysis: Sarcos Technology vs Oracle
| Metric | STRC | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $23.96B | $702.35B |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 1,947,191 | 10,188,060 |
| 90 Day Avg. Volume | 3,028,057 | 12,616,010 |
| Last Close | $97.50 | $250.05 |
| 52 Week Range | $1.38 - $97.89 | $118.86 - $260.87 |
| % from 52W High | -0.40% | -4.15% |
| All-Time High | $97.89 (Aug 08, 2025) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -0.40% | -4.15% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.11% |
| Quarterly Earnings Growth | 0.03% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.72% | 0.22% |
| Operating Margin (TTM) | -4.04% | 0.32% |
| Return on Equity (TTM) | -0.06% | 0.82% |
| Debt to Equity (MRQ) | 0.16 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | $7.29 |
| Cash per Share (MRQ) | N/A | $3.99 |
| Operating Cash Flow (TTM) | $-1,863,805,000 | $20.82B |
| Levered Free Cash Flow (TTM) | $389.10M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.83% | 0.81% |
| Last 12-Month Dividend | $0.80 | $1.70 |
Valuation & Enterprise Metrics Analysis: Sarcos Technology vs Oracle
| Metric | STRC | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 57.48 |
| Forward P/E | -2.83 | 34.92 |
| PEG Ratio | N/A | 34.92 |
| Price to Sales (TTM) | 51.71 | 12.24 |
| Price to Book (MRQ) | N/A | 34.32 |
| Market Capitalization | ||
| Market Capitalization | $23.96B | $702.35B |
| Enterprise Value | $31.17B | $800.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 67.26 | 13.95 |
| Enterprise to EBITDA | -745.74 | 34.09 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.43 |
| Book Value per Share (MRQ) | N/A | $7.29 |
Financial Statements Comparison: Sarcos Technology vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | STRC | ORCL |
|---|---|---|
| Revenue/Sales | $111.07M | $15.90B |
| Cost of Goods Sold | $33.97M | $4.74B |
| Gross Profit | $77.10M | $11.16B |
| Research & Development | $24.42M | $2.65B |
| Operating Income (EBIT) | $-15.41M | $5.19B |
| EBITDA | $-12.77M | $7.00B |
| Pre-Tax Income | $-5.94B | $4.15B |
| Income Tax | $-1.73B | $725.00M |
| Net Income (Profit) | $-4.22B | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | STRC | ORCL |
|---|---|---|
| Cash & Equivalents | $60.30M | $10.79B |
| Total Current Assets | $203.61M | $24.58B |
| Total Current Liabilities | $308.69M | $32.64B |
| Long-Term Debt | $8.19B | $96.83B |
| Total Shareholders Equity | $33.53B | $20.97B |
| Retained Earnings | $6.35B | $-15.48B |
| Property, Plant & Equipment | $81.41M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | STRC | ORCL |
|---|---|---|
| Operating Cash Flow | $-5.90B | $5.93B |
| Capital Expenditures | $-8.74M | N/A |
| Free Cash Flow | $-7.67B | $-2.92B |
| Debt Repayment | $-284,000 | $-6.07B |
| Common Stock Repurchase | N/A | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | STRC | ORCL |
|---|---|---|
| Shares Short | N/A | 20.68M |
| Short Ratio | N/A | 1.27 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 1,947,191 | 10,188,060 |
| Average Daily Volume (90 Day) | 3,028,057 | 12,616,010 |
| Shares Outstanding | 245.78M | 2.81B |
| Float Shares | N/A | 1.64B |
| % Held by Insiders | N/A | 0.42% |
| % Held by Institutions | N/A | 0.45% |
Dividend Analysis & Yield Comparison: Sarcos Technology vs Oracle
| Metric | STRC | ORCL |
|---|---|---|
| Last 12-Month Dividend | $0.80 | $1.70 |
| Last 12-Month Dividend Yield | 0.83% | 0.81% |
| 3-Year Avg Annual Dividend | $0.27 | $1.55 |
| 3-Year Avg Dividend Yield | 0.83% | 0.36% |
| 3-Year Total Dividends | $0.80 | $4.66 |
| Ex-Dividend Date | Aug 15, 2025 | Apr 10, 2025 |